SiteLabs

What SiteLabs does

SiteLabs is a US-based private health technology company operating a point-of-care testing platform designed for independent pharmacies. Founded around 2020 and incorporated in Delaware as SiteLabs Inc., the company enables independent community pharmacies to offer comprehensive diagnostic testing for common conditions, positioning these retail locations as accessible hubs for preventive care and clinical research. The company's dual-product portfolio consists of a Point-of-Care Testing Platform (the operational/clinical engine for pharmacy-based testing) integrated into a broader Community-Based Healthcare Platform that extends pharmacy capabilities into preventive screenings and clinical research participation, with explicit focus on underserved populations.

The company generates revenue through subscription/recurring fees on its healthcare platform services sold to independent pharmacies (SMB target segment), though no public pricing details or named customer logos are disclosed. SiteLabs employs a community-led go-to-market motion built on direct partnerships with independent pharmacy networks, and is pursuing integration with broader healthcare systems to extend reach. Operationally, the company is scaling from its original Seneca, South Carolina base (backed by a $250,000 SC Launch grant in October 2023) into Indianapolis, Indiana (Midwest) following a $2 million oversubscribed seed round in October 2025 led by Boomerang Ventures with participation from LabCorp Venture Fund and SC Launch. Headcount sits in the 11–50 range and total disclosed funding is approximately $2.25 million, consistent with an early-commercialization-stage business.

Name

SiteLabs

Legal name

SiteLabs Inc.

Website

https://sitelabs.site

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

SiteLabs operates a point-of-care testing platform that enables independent US pharmacies to deliver preventive care screenings, diagnostic testing, and clinical research participation, primarily serving underserved community populations.

Ownership category

akta.pro rank

Product category

Point-of-Care Testing Software

NAICS

Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)

akta.pro secondary industry

Point-of-Care & Decentralized Trial Testing Services (HLAGAEAK)

Keywords

• Point-of-care testing
• Pharmacy healthcare platform
• Preventive care services
• Clinical research platform
• Community health technology

Headquarters

HQ city

Anderson

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations

Revenue model

1. Healthcare Platform Services: SiteLabs generates revenue through its community-based healthcare platform that transforms independent pharmacies into access points for preventive care and clinical research. The platform enables pharmacies to offer comprehensive testing services.

Go-to-market motion1 record

Distribution channels1 record

Core offering

SiteLabs provides a point-of-care testing platform that enables independent pharmacies to offer comprehensive testing services for common conditions. Its broader community-based healthcare platform extends those pharmacies into access points for preventive care screenings and clinical research participation, addressing healthcare gaps for underserved populations in the U.S. Midwest and Southeast.

Product overview

SiteLabs offers a dual-product portfolio focused on community healthcare transformation. The core Point-of-Care Testing Platform enables independent pharmacies to conduct comprehensive diagnostic testing for common conditions. This platform is integrated into the broader Community-Based Healthcare Platform, which extends pharmacy capabilities into preventive care screenings and clinical research participation. Together, these products position independent pharmacies as accessible healthcare hubs for underserved communities.

Differentiator

Problem solved

Functional benefit

Products and services

• Point-of-Care Testing Platform

Quantifiable outcome

• Expanding platform reach to transform independent pharmacies into preventive care and clinical research access points

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Truvian Health: Truvian Health is developing a benchtop point-of-care blood testing platform that delivers rapid diagnostic results in retail and community settings. It is a direct analogue to SiteLabs' vision of bringing comprehensive testing to non-traditional care access points.
• Health Mart (McKesson): Health Mart is McKesson's franchise network of independent community pharmacies. It is directly comparable to SiteLabs because both serve the same independent pharmacy channel and enable those pharmacies to deliver enhanced clinical services.
• Cue Health: Cue Health is a connected point-of-care molecular diagnostics platform that delivers lab-quality testing at home and in decentralized settings. Like SiteLabs, it focuses on extending professional-grade diagnostics outside of centralized labs via connected hardware and software workflows.
• CPESN USA: CPESN USA is a national network of community-based pharmacies providing enhanced clinical services. It is a directly comparable channel and concept — turning independent pharmacies into healthcare delivery hubs — that SiteLabs targets as its distribution and service backbone.
• Babson Diagnostics: Babson Diagnostics offers decentralized, retail-based blood testing via small-volume sample collection in community locations. Its retail-channel model and focus on underserved, convenient testing are closely aligned with SiteLabs' pharmacy-led preventive care thesis.

Broad incumbents

• CVS Health: CVS operates MinuteClinic and Oak Street Health, delivering point-of-care testing, preventive care, and clinical research inside its pharmacy and retail locations. It is the largest established player in retail-based clinical services.
• Walgreens Boots Alliance: Walgreens, via VillageMD and other owned clinical assets, is rolling out point-of-care testing and primary care services across its retail footprint. It overlaps with SiteLabs' preventive-care-in-retail-pharmacy thesis at much larger scale.
• Walmart Health: Walmart Health integrates primary care, diagnostics, and preventive services in retail settings. As a broad incumbent pursuing community-based care, it competes for the same preventive-care-in-retail demand SiteLabs targets via independent pharmacies.

Emerging players

• AdhereHealth: AdhereHealth works with pharmacies and health plans to deliver medication adherence and chronic condition management programs. It overlaps with SiteLabs on the pharmacy-as-care-channel model and chronic-condition preventive care workflows.
• Rheonix: Rheonix develops automated molecular diagnostics for decentralized and point-of-care testing. Its focus on low-complexity, high-throughput community diagnostics is adjacent to SiteLabs' POC platform thesis.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/sitelabsglobal
• LinkedInlinkedin.com/company/sitelabsglobal

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SiteLabs